NeurAxis (NRXS) has been awarded a Veterans Affairs Federal Supply Schedule contract, effective December 1, 2025. The first product listed on the FSS is the IB-Stim, a drug-free treatment for functional abdominal pain in patients 8 years and older. This contract award establishes NeurAxis as a federal contractor and creates a clear commercial pathway into the VA health system, which serves nearly 7 million active patients annually. The Company expects the VA award, combined with broadening reimbursement and increasing clinical adoption, to support sustained commercial momentum entering 2026.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NRXS: